Lucintel's latest market report analyzed that liquid biopsy provides attractive opportunities in reference laboratories, hospitals and physician laboratories, and academic and research centers. The liquid biopsy market is expected to reach $9.3 billion by 2026 with a CAGR of 17%. In this market, circulating tumor DNA is the largest segment by circulating biomarker, whereas therapy selection is largest by clinical application. The usage of methylation-specific polymerase chain reaction (MS-PCR) liquid biopsy technology and the emergence of hybrid ctDNA and CTC target selector provides strategic growth path in this market.
Download Brochure of this report by clicking on https://www.lucintel.com/liquid-biopsy-market.aspx
Based on circulating biomarker, the liquid biopsy market is segmented into circulating
tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA),
extracellular vesicles (EVs), and other biomarkers. The circulating tumor DNA
(ctDNA)segment accounted for the largest share of the market in 2020 and is
expected to register the highest CAGR during the forecast period, due to increasing
use of ctDNA biomarkers in next-generation sequencing (NGS) technologies for
detecting disease in real time and in early stage.
Browse in-depth TOC on “Liquid
Biopsy Market”
129 – Tables
163 – Figures
264 – Pages
The liquid biopsy market
is marked by the presence of several big and small players. Some of the
prominent players offering Liquid biopsy include Guardant, Bio-Rad
Laboratories, Qaigen, MDxHealth, Myraid, Biocept, Roche, Illumina, and
Thermofisher.
Request Sample Report:
https://www.lucintel.com/liquid-biopsy-market.aspx
This unique research report will enable you
to make confident business decisions in this globally competitive marketplace. For
a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on
this link helpdesk@lucintel.com.
About Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon Fitzgerald
Lucintel
Dallas,
Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Global
Diagnostic Imaging Market:
For more details click here https://www.lucintel.com/diagnostic-imaging-market.aspx
Medical
Battery Market Report:
For more details click here https://www.lucintel.com/medical-battery-market.aspx
Medical Device Market Report:
For more details click here https://www.lucintel.com/medical-device-market.aspx
Wheelchair Market Report:
For more details click here https://www.lucintel.com/wheelchair-market.aspx
Interventional Cardiology and Peripheral Vascular
Device Market Report:
For more details click here https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx
Stretcher Market Report:
For more details click here https://www.lucintel.com/stretcher-market.aspx
Stent
Market Report:
For more details click here https://www.lucintel.com/stents-market.aspx
Medical Lifting Sling Market Report:
For more details click here https://www.lucintel.com/medical-lifting-sling-market.aspx
3D
Printing Medical Device Market Report:
For more details click here https://www.lucintel.com/3d-printing-medical-device-market.aspx
Hand Sanitizer Market Report:
No comments:
Post a Comment